Weill Cornell Medicine Multiple Sclerosis Center

Publications

Found 6 results

Filters: Author is Gauthier, Susan A [Clear All Filters]

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

C

Wang Y, Spincemaille P, Liu Z, Dimov A, Deh K, Li J, Zhang Y, Yao Y, Gillen KM, Wilman AH et al.. 2017. Clinical quantitative susceptibility mapping (QSM): Biometal imaging and its emerging roles in patient care.. J Magn Reson Imaging. 46(4):951-971.

I

Eskreis-Winkler S, Zhou D, Liu T, Gupta A, Gauthier SA, Wang Y, Spincemaille P. 2017. On the influence of zero-padding on the nonlinear operations in Quantitative Susceptibility Mapping.. Magn Reson Imaging. 35:154-159.

M

Dayan M, Rúa SMHurtado, Monohan E, Fujimoto K, Pandya S, LoCastro EM, Vartanian T, Nguyen TD, Raj A, Gauthier SA. 2017. MRI Analysis of White Matter Myelin Water Content in Multiple Sclerosis: A Novel Approach Applied to Finding Correlates of Cortical Thinning.. Front Neurosci. 11:284.

N

Kappos L, Havrdova E, Giovannoni G, Khatri BO, Gauthier SA, Greenberg SJ, You X, Wang P, Giannattasio G. 2017. No evidence of disease activity in patients receiving daclizumab versus intramuscular interferon beta-1a for relapsing-remitting multiple sclerosis in the DECIDE study.. Mult Scler. 23(13):1736-1747.

R

Kaunzner UW, Kang Y, Monohan E, Kothari PJ, Nealon N, Perumal J, Vartanian T, Kuceyeski A, Vallabhajosula S, P Mozley D et al.. 2017. Reduction of PK11195 uptake observed in multiple sclerosis lesions after natalizumab initiation.. Mult Scler Relat Disord. 15:27-33.

S

Kaunzner UW, Kumar G, Askin G, Gauthier SA, Nealon N, Vartanian T, Perumal J. 2016. A study of patients with aggressive multiple sclerosis at disease onset.. Neuropsychiatr Dis Treat. 12:1907-12.